Literature DB >> 1527018

Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis.

J A Wingrove1, R G DiScipio, Z Chen, J Potempa, J Travis, T E Hugli.   

Abstract

Complement components C3 and C5 are susceptible to limited proteolysis by an arginine-specific cysteine proteinase isolated from Porphyromonas gingivalis. This bacterium is an anaerobe commonly associated with severe periodontal disease. Infection by P. gingivalis is accompanied by an acute inflammatory response, complete with extensive neutrophil involvement. This prompted us to investigate a possible direct role for complement in periodontitis evoked by P. gingivalis. Exposure of C3 and C5 to the cysteine proteinase at molar ratios between 1:25 and 1:100 (enzyme to substrate ratios) resulted in a time-dependent, limited degradation of each component. C3 was converted in a stepwise manner to C3a-like and C3b-like fragments with evidence of extensive further degradation of the C3a-like portion of the molecule. We were unable to demonstrate C3a activity in the C3 digestion mixtures. C3 degradation appears to involve primarily the alpha-chain. Proteolysis of C5 also progresses in a stepwise manner producing an initial internal cleavage of the alpha-chain to generate 30- and 86-kDa fragments. Further digestion of the 86-kDa amino-terminal fragment of the alpha-chain leads to the release of C5a or a C5a-like fragment that is biologically active for neutrophil activation. The fact that a potent chemotactic factor, i.e. C5a, can be generated from C5 by a proteinase derived from P. gingivalis suggests a recruiting mechanism for attracting neutrophils to the gingival lesion site in periodontal disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1527018

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  78 in total

1.  Salivary histatin 5 is an inhibitor of both host and bacterial enzymes implicated in periodontal disease.

Authors:  H Gusman; J Travis; E J Helmerhorst; J Potempa; R F Troxler; F G Oppenheim
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

2.  Feasibility of an HA2 domain-based periodontitis vaccine.

Authors:  A A DeCarlo; Y Huang; C A Collyer; D B Langley; J Katz
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

3.  Characterization of an adherence and antigenic determinant of the ArgI protease of Porphyromonas gingivalis which is present on multiple gene products.

Authors:  M A Curtis; J Aduse-Opoku; J M Slaney; M Rangarajan; V Booth; J Cridland; P Shepherd
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

4.  Citrullination and proteolytic processing of chemokines by Porphyromonas gingivalis.

Authors:  Eva A V Moelants; Gitte Loozen; Anneleen Mortier; Erik Martens; Ghislain Opdenakker; Danuta Mizgalska; Borys Szmigielski; Jan Potempa; Jo Van Damme; Wim Teughels; Paul Proost
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

5.  A metalloproteinase karilysin present in the majority of Tannerella forsythia isolates inhibits all pathways of the complement system.

Authors:  Monika Jusko; Jan Potempa; Abdulkarim Y Karim; Miroslaw Ksiazek; Kristian Riesbeck; Peter Garred; Sigrun Eick; Anna M Blom
Journal:  J Immunol       Date:  2012-01-27       Impact factor: 5.422

6.  Gingipain of Porphyromonas gingivalis manipulates M1 macrophage polarization through C5a pathway.

Authors:  Yubo Hou; Haiyan Yu; Xinchan Liu; Gege Li; Jiahui Pan; Changyu Zheng; Weixian Yu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-06-20       Impact factor: 2.416

7.  A functional virulence complex composed of gingipains, adhesins, and lipopolysaccharide shows high affinity to host cells and matrix proteins and escapes recognition by host immune systems.

Authors:  Ryosuke Takii; Tomoko Kadowaki; Atsuyo Baba; Takayuki Tsukuba; Kenji Yamamoto
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

8.  A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice.

Authors:  C A Genco; B M Odusanya; J Potempa; J Mikolajczyk-Pawlinska; J Travis
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Genetic and intervention studies implicating complement C3 as a major target for the treatment of periodontitis.

Authors:  Tomoki Maekawa; Toshiharu Abe; Evlambia Hajishengallis; Kavita B Hosur; Robert A DeAngelis; Daniel Ricklin; John D Lambris; George Hajishengallis
Journal:  J Immunol       Date:  2014-05-07       Impact factor: 5.422

10.  Discrete proteolysis of focal contact and adherens junction components in Porphyromonas gingivalis-infected oral keratinocytes: a strategy for cell adhesion and migration disabling.

Authors:  Edith Hintermann; Susan Kinder Haake; Urs Christen; Andrew Sharabi; Vito Quaranta
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.